Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Mol Cell Biol ; 15(9): 4745-53, 1995 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-7651392

RESUMO

Normal cells have a strictly limited growth potential and senesce after a defined number of population doublings (PDs). In contrast, tumor cells often exhibit an apparently unlimited proliferative potential and are termed immortalized. Although spontaneous immortalization of normal human cells in vitro is an extremely rare event, we observed this in fibroblasts from an affected member of a Li-Fraumeni syndrome kindred. The fibroblasts were heterozygous for a p53 mutation and underwent senescence as expected at PD 40. In four separate senescent cultures (A to D), there were cells that eventually recommenced proliferation. This was associated with aneuploidy in all four cultures and either loss (cultures A, C, and D) or mutation (culture B) of the wild-type (wt) p53 allele. Loss of wt p53 function was insufficient for immortalization, since cultures A, B, and D subsequently entered crisis from which they did not escape. Culture C has continued proliferating beyond 400 PDs and thus appears to be immortalized. In contrast to the other cultures, the immortalized cells have no detectable p16INK4 protein. A culture that had a limited extension of proliferative potential exhibited a progressive decrease in telomere length with increasing PD. In the culture that subsequently became immortalized, the same trend occurred until PD 73, after which there was a significant increase in the amount of telomeric DNA, despite the absence of telomerase activity. Immortalization of these cells thus appears to be associated with loss of wt p53 and p16INK4 expression and a novel mechanism for the elongation of telomeres.


Assuntos
Proteínas de Transporte/genética , Transformação Celular Neoplásica/genética , Síndrome de Li-Fraumeni/genética , Telômero/genética , Proteína Supressora de Tumor p53/genética , Animais , Sequência de Bases , Testes de Carcinogenicidade , Células Cultivadas , Senescência Celular/genética , Aberrações Cromossômicas , Inibidor p16 de Quinase Dependente de Ciclina , DNA Nucleotidilexotransferase/análise , Fibroblastos , Heterozigoto , Cariotipagem , Síndrome de Li-Fraumeni/enzimologia , Camundongos , Camundongos Nus , Dados de Sequência Molecular , Mutação , Neoplasias Experimentais , Ploidias , Proteína do Retinoblastoma/metabolismo , Telômero/metabolismo
2.
Cancer Res ; 58(16): 3508-12, 1998 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-9721850

RESUMO

Inactivation of p16INK4 tumor suppressor gene function is frequently observed in breast cancer. We examined p16INK4 expression in human mammary epithelial cell (HMEC) cultures established from four normal donors. Normal HMECs divide a limited number of times before proliferation ceases in a state referred to as selection (or M0). The cell subpopulation that emerges spontaneously from selection undergoes a further limited period of proliferation before senescence. By immunofluorescence and Western blot analysis of four independent cultures, we have shown loss of p16INK4 expression in postselection HMECs. In contrast, p16INK4 was present in both early and late passage fibroblasts from the same individuals. Bisulfite genomic sequencing revealed extensive methylation of the p16INK4 CpG island in post- but not preselection cells. Thus, the extended period of growth observed in postselection HMECs is associated with hypermethylation of the p16INK4 CpG island and loss of p16INK4 expression. Although postselection HMECs are widely considered to be normal, these data indicate that they have sustained an epigenetic alteration.


Assuntos
Mama/citologia , Inibidor p16 de Quinase Dependente de Ciclina/metabolismo , Genes p16 , Divisão Celular/genética , Sobrevivência Celular , Células Cultivadas , Inibidor p16 de Quinase Dependente de Ciclina/genética , Células Epiteliais/metabolismo , Feminino , Humanos , Metilação
3.
Oncogene ; 18(22): 3383-90, 1999 Jun 03.
Artigo em Inglês | MEDLINE | ID: mdl-10362359

RESUMO

Some immortalized cell lines maintain their telomeres in the absence of detectable telomerase activity by an alternative (ALT) mechanism. To study how telomere maintenance is controlled in ALT cells, we have fused an ALT cell line GM847 (SV40 immortalized human skin fibroblasts) with normal fibroblasts or with telomerase positive immortal human cell lines and have examined their proliferative potential and telomere dynamics. The telomeres in ALT cells are characteristically very heterogeneous in length, ranging from very short to very long. The ALT x normal hybrids underwent a rapid reduction in telomeric DNA and entered a senescence-like state. Immortal segregants rapidly reverted to the ALT telomere phenotype. Fusion of ALT cells to telomerase-positive immortal cells in the same immortalization complementation group resulted in hybrids that appeared immortal and also exhibited repression of the ALT telomere phenotype. In these hybrids, which were all telomerase-positive, we observed an initial rapid loss of most long telomeres, followed either by gradual loss of the remaining long telomeres at a rate similar to the rate of telomere shortening in normal telomerase-negative cells, or by maintenance of shortened telomeres. These data indicate the existence of a mechanism of rapid telomere deletion in human cells. They also demonstrate that normal cells and at least some telomerase-positive immortal cells contain repressors of the ALT telomere phenotype.


Assuntos
Células Híbridas/fisiologia , Telômero/genética , Divisão Celular/genética , Fusão Celular , Senescência Celular/genética , Fibroblastos/citologia , Teste de Complementação Genética , Humanos , Telomerase/metabolismo
4.
Exp Gerontol ; 32(6): 663-70, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9785092

RESUMO

Previous somatic cell hybridization studies have assigned many human cell lines to one of four complementation groups (A-D) for immortalization. We report here that the A1698DM cell line, which contains selectable markers and has previously been defined as the immortalization group D representative, was derived from T24 cells rather than A1698. A1698DM did not undergo senescence when fused with cell lines assigned to groups A, B, or C. This raises the possibility that this cell line has undergone further evolution and lost multiple putative senescence genes so that it is now unable to complement any, or most, other cell lines for senescence. Cell lines previously assigned to group D may, therefore, be heterogeneous with respect to the genetic changes that resulted in their immortalization. This has important implications for strategies to clone senescence genes based on complementation groups.


Assuntos
Linhagem Celular Transformada/classificação , Linhagem Celular Transformada/fisiologia , Células Tumorais Cultivadas/classificação , Células Tumorais Cultivadas/fisiologia , Fusão Celular , Senescência Celular/fisiologia , Mapeamento Cromossômico , Impressões Digitais de DNA , Teste de Complementação Genética , Marcadores Genéticos , Humanos , Células Híbridas/fisiologia , Cariotipagem
5.
Exp Cell Res ; 205(2): 337-44, 1993 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-8387017

RESUMO

Human cell lines have been assigned to four complementation groups for immortalization [O.M. Pereira-Smith and J. R. Smith, Proc. Natl. Acad. Sci. USA 85, 6042-6046, 1988]. Three SV40-immortalized epithelial cell lines were fused to cell lines representative of each of these four complementation groups. All three formed senescent hybrids with an SV40-immortalized cell line representative of group A, indicating that SV40 genes do not always cause immortalization via the same genetic mechanism. In contrast to the results of studies with other human cell lines, each of these three cell lines was assigned to more than one complementation group for immortalization. Thus these cell lines may have lost the function of two or more putative senescence genes.


Assuntos
Transformação Celular Viral , Senescência Celular , Vírus 40 dos Símios/genética , Divisão Celular , Fusão Celular , Linhagem Celular , Impressões Digitais de DNA , Teste de Complementação Genética , Humanos , Células Híbridas/citologia , Técnicas In Vitro
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA